E-Guide: Drug Pricing Reform Bursts Insulin Bubble — What to Expect in 2024

Congressional oversight has recently fixated on exorbitant inflation in insulin costs – such extreme and consistent price increases over many years that even reasonably insured patients may experience access issues. This is a critical concern for US public health, as estimates by the American Diabetes Association (ADA) suggest that approximately 8.4 million Americans with diabetes rely on insulin.

Our e-guide tells you what you need to know about these policies, the current insulin landscape, and what to expect in 2024.

Read/Download the e-Guide